Anti-HPV58 Major capsid protein L1 Antibody (2C3)

Catalog No.

RVV19509

Species reactivity

Human papillomavirus 58 (HPV58)

Host species

Mouse

Isotype

IgG1

Clonality

Monoclonal

Target

L1, Major capsid protein L1

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

P26535

Applications

ELISA-cap, Neutralization

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Clone ID

2C3

[The soluble expression and application of human papillomavirus type 58 (HPV58) major capsid protein L1]., PMID:35732612

Combined truncations at both N- and C-terminus of human papillomavirus type 58 L1 enhanced the yield of virus-like particles produced in a baculovirus system., PMID:34890711

Worldwide genetic variations in high-risk human papillomaviruses capsid L1 gene and their impact on vaccine efficiency., PMID:33636291

Comprehensive Assessment of the Antigenic Impact of Human Papillomavirus Lineage Variation on Recognition by Neutralizing Monoclonal Antibodies Raised against Lineage A Major Capsid Proteins of Vaccine-Related Genotypes., PMID:32967963

Impact of Naturally Occurring Variation in the Human Papillomavirus 58 Capsid Proteins on Recognition by Type-Specific Neutralizing Antibodies., PMID:29905865

Human papillomavirus 16L1-58L2 chimeric virus-like particles elicit durable neutralizing antibody responses against a broad-spectrum of human papillomavirus types., PMID:28968993

Crystal Structures of Two Immune Complexes Identify Determinants for Viral Infectivity and Type-Specific Neutralization of Human Papillomavirus., PMID:28951471

Broad Cross-Protection Is Induced in Preclinical Models by a Human Papillomavirus Vaccine Composed of L1/L2 Chimeric Virus-Like Particles., PMID:27147749

Seroprevalence of 10 human papillomavirus types in the general rural population of Anyang, China: a cross-sectional study., PMID:25999521

Pre-clinical immunogenicity of human papillomavirus alpha-7 and alpha-9 major capsid proteins., PMID:25203446

Amino acid sequence diversity of the major human papillomavirus capsid protein: implications for current and next generation vaccines., PMID:23722024

[Preparation and identification of type specific and conformation dependent HPV16 L1 protein monoclonal antibody.]., PMID:19961800

Identification of two cross-neutralizing linear epitopes within the L1 major capsid protein of human papillomaviruses., PMID:12050360

[Expression of the human papillomavirus type 58L1 capsid protein in E.coli and preparation of the HPV58 L1 mouse antiserum]., PMID:11986714

Document Download

Anti-HPV58 Major capsid protein L1 Antibody (2C3).pdf